-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Case #2.Multifocal Bone Lesions and Profound Lymphopenia that is Not Langerhans Histiocytosis

Program: Spotlight Sessions
Session: Vascular Anomalies 101: Case-Based Discussion on the Diagnosis, Treatment and Lifelong Care of These Patients
Monday, December 7, 2020, 6:55 AM-7:00 AM

Denise M Adams, MD1 and Miikka Vikkula, MD, PhD2*

1Children's Hospital of Philadelphia, Philadelphia, PA
2Universite Catholique De Louvain, Brussels, Belgium

Disclosures: Adams: Venthura: Consultancy; Novartis: Consultancy.

OffLabel Disclosure: Rapamycin

<< Previous Presentation | Next Presentation